Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus

Anti-embolism devices therapy to improve the ICU mortality rate of patients with acute myocardial infarction and type II diabetes mellitus

BackgroundAnti-Embolism (AE) devices therapy is an additional antithrombotic treatment that is effective in many venous diseases, but the correlations between this medical compression therapy and cardiovascular arterial disease or comorbid diabetes mellitus (DM) are still controversial. In this stud...

Full description

Bibliographic Details
Main Authors: Xiaxuan Huang, Luming Zhang, Mengyuan Xu, Shiqi Yuan, Yan Ye, Tao Huang, Haiyan Yin, Jun Lyu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
anti-embolic therapy
acute myocardial infarction
type II diabetes mellitus
mortality
ICU
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.948924/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.948924/full

Similar Items